Orchid Biosciences - Update - Climbing Higher On News [ORCH]
12/21/01 8:42:07 AM We alerted readers at 8:13 that Orchid Biosciences (ORCH) expects to beat consensus revenue estimates for the fourth quarter and had reaffirmed its full year 2002 guidance. The stock is currently trading higher by 0.75 on 14K shares before the bell on Friday.
Orchid Biosciences is a thinly traded stock that was ran-bound throughout Thursday's session and closed down by 0.13 at $4.30 on average volume.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.